
<p>{{Infobox_Disease}}</p>
<p><b>Crohn&#39;s disease</b> (also known as <b>regional enteritis</b>) is a <a href="/wiki/Chronic_(medicine)" id="w">chronic</a>, episodic, <a href="/wiki/Inflammation" id="w">inflammatory</a> condition of the <a href="/wiki/Gastrointestinal_tract" id="w">gastrointestinal tract</a> characterized by transmural inflammation (affecting the entire wall of the involved bowel) and skip lesions (areas of inflammation with areas of normal lining between). Crohn&#39;s disease is a type of <a href="/wiki/Inflammatory_bowel_disease" id="w">inflammatory bowel disease</a> (IBD) and can affect any part of the gastrointestinal tract from <a href="/wiki/Mouth" id="w">mouth</a> to <a href="/wiki/Anus" id="w">anus</a>; as a result, the symptoms of Crohn&#39;s disease vary among afflicted individuals.  The main gastrointestinal symptoms are <a href="/wiki/Abdominal_pain" id="w">abdominal pain</a>, <a href="/wiki/Diarrhea" id="w">diarrhea</a> (which may be bloody) or <a href="/wiki/Constipation" id="w">constipation</a>, <a href="/wiki/Vomiting" id="w">vomiting</a> and <a href="/wiki/Weight_loss" id="w">weight loss</a>.  Crohn&#39;s disease can also cause complications outside of the gastrointestinal tract such as skin rashes, <a href="/wiki/Arthritis" id="w">arthritis</a>, and <a href="/wiki/Uveitis" id="w">inflammation of the eye</a>.<sup id="_ref-Hanauer_a" class="reference"><a href="#_note-Hanauer" title="">[1]</a></sup></p>
<p>The disease was independently described in 1904 by Polish surgeon <a href="/wiki/Antoni_Lesniowski" id="w">Antoni Lesniowski</a> and in 1932 by American <a href="/wiki/Gastroenterology" id="w">gastroenterologist</a> <a href="/wiki/Burrill_Bernard_Crohn" id="w">Burrill Bernard Crohn</a>, for whom the disease was eponymized.  Dr. Crohn, along with two colleagues, described a series of patients with inflammation of the <a href="/wiki/Terminal_ileum" id="w">terminal ileum</a>, the area most commonly affected by the illness.<sup id="_ref-CrohnBB_a" class="reference"><a href="#_note-CrohnBB" title="">[2]</a></sup> Crohn&#39;s disease affects between 400,000 and 600,000 people in North America.<sup id="_ref-Loftus_a" class="reference"><a href="#_note-Loftus" title="">[3]</a></sup>
Prevalence estimates for Northern Europe have ranged from 27–48 per 100,000.<sup id="_ref-Bernstein_a" class="reference"><a href="#_note-Bernstein" title="">[4]</a></sup> Crohn&#39;s disease often develops in the teenage years, though individuals in their earlier years are also at increased risk.<sup id="_ref-Hanauer_b" class="reference"><a href="#_note-Hanauer" title="">[1]</a></sup><sup id="_ref-emed_a" class="reference"><a href="#_note-emed" title="">[5]</a></sup> There is a <a href="/wiki/Genetics" id="w">genetic</a> component to susceptibility with highest relative risk in siblings, affecting males and females equally. Smokers are three times more likely to get Crohn&#39;s disease.</p> 
<p>Although the cause of Crohn&#39;s disease is not known, it is believed to be an <a href="/wiki/Autoimmunity" id="w">autoimmune disease</a> that is genetically linked. The condition occurs when the immune system contributes to damage of the gastrointestinal tract by causing inflammation.  </p>
<p>Unlike the other major type of IBD, <a href="/wiki/Ulcerative_colitis" id="w">ulcerative colitis</a>, there is no known medical or <a href="/wiki/Surgery" id="w">surgical</a> cure for Crohn&#39;s disease.<sup id="_ref-6" class="reference"><a href="#_note-6" title="">[6]</a></sup>  Instead, a number of medical treatments are utilized with the goal of putting and keeping the disease in <a href="/wiki/Remission_(medicine)" id="w">remission</a>.  These include <a href="/wiki/Mesalazine" id="w">5-aminosalicylic acid</a> (5-ASA) formulations (Pentasa capsules, Asacol tablets, Lialda tablets, Rowasa retention enemas), <a href="/wiki/Prednisone" id="w">steroid</a> medications, immunomodulators (such as <a href="/wiki/Azathioprine" id="w">azathioprine</a>, <a href="/wiki/Mercaptopurine" id="w">mercaptopurine</a> (6-MP), and <a href="/wiki/Methotrexate" id="w">methotrexate</a>), and newer <a href="/wiki/Biological_therapy_for_inflammatory_bowel_disease" id="w">biological</a> medications, such as <a href="/wiki/Infliximab" id="w">infliximab</a> (Remicade) and <a href="/wiki/Adalimumab" id="w">adalimumab</a> (Humira).<sup id="_ref-Podolsky_a" class="reference"><a href="#_note-Podolsky" title="">[7]</a></sup></p>
<a id="Classification" name="Classification"></a><h1>Classification</h1>
<p><div style="wigth:250px"><a class="internal" href="/wiki/Image:250px-Distribution_of_CD.svg.png" title="Distribution of gastrointestinal Crohn&#39;s disease.  Based on data from [[American Gastroenterological Association]]."><img src="http://en.wikipedia.org/wiki/250px-Distribution_of_CD.svg.png" alt="Distribution of gastrointestinal Crohn&#39;s disease.  Based on data from [[American Gastroenterological Association]]." title="Distribution of gastrointestinal Crohn&#39;s disease.  Based on data from [[American Gastroenterological Association]]." class="location-right type-thumb" width="250px" />
</a>
<div class="thumbcaption">Distribution of gastrointestinal Crohn&#39;s disease.  Based on data from <a href="/wiki/American_Gastroenterological_Association" id="w">American Gastroenterological Association</a>.</div></div>

Crohn&#39;s disease almost invariably affects the gastrointestinal tract. As a result, most gastroenterologists classify the disease by the affected areas. <b><i>Ileocolic Crohn&#39;s disease</i></b>, which affects both the <a href="/wiki/Ileum" id="w">ileum</a> (the last part of the <a href="/wiki/Small_intestine" id="w">small intestine</a> that connects to the <a href="/wiki/Large_intestine" id="w">large intestine</a>) and the large intestine, accounts for fifty percent of cases. <b><i>Crohn&#39;s ileitis</i></b>, affecting the ileum only, accounts for thirty percent of cases, and <b><i>Crohn&#39;s colitis</i></b>, affecting the large intestine, accounts for the remaining twenty percent of cases, and may be particularly difficult to distinguish from ulcerative colitis. The disease can attack any part of the digestive tract, from <a href="/wiki/Mouth" id="w">mouth</a> to <a href="/wiki/Anus" id="w">anus</a>. However, individuals affected by the disease rarely fall outside these three classifications, being affected in other parts of the gastrointestinal tract such as the <a href="/wiki/Stomach" id="w">stomach</a> and <a href="/wiki/Esophagus" id="w">esophagus</a>.<sup id="_ref-Hanauer_c" class="reference"><a href="#_note-Hanauer" title="">[1]</a></sup>
Crohn&#39;s disease may also be classified by the behaviour of disease as it progresses. This was formalized in the Vienna classification of Crohn&#39;s disease.<sup id="_ref-Vienna_a" class="reference"><a href="#_note-Vienna" title="">[8]</a></sup>  There are three categories of disease presentation in Crohn&#39;s disease: stricturing, penetrating, and inflammatory. <i>Stricturing disease</i> causes narrowing of the bowel which may lead to <a href="/wiki/Bowel_obstruction" id="w">bowel obstruction</a> or changes in the caliber of the <a href="/wiki/Feces" id="w">feces</a>. <i>Penetrating disease</i> creates abnormal passageways (<a href="/wiki/Fistula" id="w">fistulae</a>) between the bowel and other structures such as the skin. <i>Inflammatory disease</i> (or non-stricturing, non-penetrating disease) causes inflammation without causing strictures or fistulae.<sup id="_ref-Vienna_b" class="reference"><a href="#_note-Vienna" title="">[8]</a></sup><sup id="_ref-phenotypes_a" class="reference"><a href="#_note-phenotypes" title="">[9]</a></sup></p>
<a id="Symptoms" name="Symptoms"></a><h1>Symptoms</h1>

<p><div style="wigth:200px"><a class="internal" href="/wiki/Image:200px-CD_serpiginous_ulcer.jpg" title="Endoscopy image of [[colon (anatomy)|colon]] showing [[serpiginous]] ulcer, a classic finding in Crohn&#39;s disease"><img src="http://en.wikipedia.org/wiki/200px-CD_serpiginous_ulcer.jpg" alt="Endoscopy image of [[colon (anatomy)|colon]] showing [[serpiginous]] ulcer, a classic finding in Crohn&#39;s disease" title="Endoscopy image of [[colon (anatomy)|colon]] showing [[serpiginous]] ulcer, a classic finding in Crohn&#39;s disease" class="location-right type-thumb" width="200px" />
</a>
<div class="thumbcaption">Endoscopy image of <a href="/wiki/Colon_(anatomy)" id="w">colon</a> showing <a href="/wiki/Serpiginous" id="w">serpiginous</a> ulcer, a classic finding in Crohn&#39;s disease</div></div>

Many people with Crohn&#39;s disease have symptoms for years prior to the diagnosis.<sup id="_ref-Pimentel_a" class="reference"><a href="#_note-Pimentel" title="">[10]</a></sup> The usual onset is between 15 and 30 years of age but can occur at any age.<sup id="_ref-11" class="reference"><a href="#_note-11" title="">[11]</a></sup> Because of the patchy nature of the gastrointestinal disease and the depth of tissue involvement, initial symptoms can be more vague than with ulcerative colitis. People with Crohn&#39;s disease will go through periods of flare-ups and remission.  </p>
<dl><dt>Gastrointestinal symptoms</dt></dl>
<p><a href="/wiki/Abdominal_pain" id="w">Abdominal pain</a> may be the initial symptom of Crohn&#39;s disease. The pain is commonly <a href="/wiki/Cramp" id="w">cramp-like</a> and may be relieved by <a href="/wiki/Defecate" id="w">defecation</a>. It is often accompanied by <a href="/wiki/Diarrhea" id="w">diarrhea</a>, which may or may not be bloody, though constipation is not uncommon especially in those who have had surgery. The nature of the diarrhea in Crohn&#39;s disease depends on the part of the small intestine or colon that is involved. Ileitis typically results in large-volume watery feces. Colitis may result in a smaller volume of feces of higher frequency. Fecal consistency may range from solid to watery. In severe cases, an individual may have more than 20 <a href="/wiki/Bowel_movements" id="w">bowel movements</a> per day and may need to awaken at night to defecate.<sup id="_ref-Hanauer_d" class="reference"><a href="#_note-Hanauer" title="">[1]</a></sup><sup id="_ref-emed_b" class="reference"><a href="#_note-emed" title="">[5]</a></sup><sup id="_ref-Podolsky_b" class="reference"><a href="#_note-Podolsky" title="">[7]</a></sup><sup id="_ref-12" class="reference"><a href="#_note-12" title="">[12]</a></sup> Visible bleeding in the feces is less common in Crohn&#39;s disease than in ulcerative colitis, but may be seen in the setting of Crohn&#39;s colitis.<sup id="_ref-Hanauer_e" class="reference"><a href="#_note-Hanauer" title="">[1]</a></sup> Bloody bowel movements are typically intermittent, and may be bright or dark red in colour. In the setting of severe Crohn&#39;s colitis, bleeding may be copious.<sup id="_ref-emed_c" class="reference"><a href="#_note-emed" title="">[5]</a></sup> <a href="/wiki/Flatus" id="w">Flatus</a> and bloating may also add to the intestinal discomfort.<sup id="_ref-emed_d" class="reference"><a href="#_note-emed" title="">[5]</a></sup> </p>
<p>Symptoms caused by intestinal <a href="/wiki/Stenosis" id="w">stenosis</a> are also common in Crohn&#39;s disease. Abdominal pain is often most severe in areas of the bowel with stenoses. In the setting of severe stenosis, <a href="/wiki/Vomiting" id="w">vomiting</a> and <a href="/wiki/Nausea" id="w">nausea</a> may indicate the beginnings of small <a href="/wiki/Bowel_obstruction" id="w">bowel obstruction</a>.<sup id="_ref-emed_e" class="reference"><a href="#_note-emed" title="">[5]</a></sup> Crohn&#39;s disease may also be associated with <a href="/wiki/Primary_sclerosing_cholangitis" id="w">primary sclerosing cholangitis</a>, a type of inflammation of the bile ducts.</p>
<p>Perianal discomfort may also be prominent in Crohn&#39;s disease. Itchiness or pain around the <a href="/wiki/Anus" id="w">anus</a> may be suggestive of inflammation, <a href="/wiki/Fistula" id="w">fistulization</a> or <a href="/wiki/Abscess" id="w">abscess</a> around the anal area<sup id="_ref-Hanauer_f" class="reference"><a href="#_note-Hanauer" title="">[1]</a></sup> or <a href="/wiki/Anal_fissure" id="w">anal fissure</a>. Perianal skin <a href="/wiki/Acrochordon" id="w">tags</a> are also common in Crohn&#39;s disease.<sup id="_ref-13" class="reference"><a href="#_note-13" title="">[13]</a></sup> <a href="/wiki/Fecal_incontinence" id="w">Fecal incontinence</a> may accompany peri-anal Crohn&#39;s disease. At the opposite end of the gastrointestinal tract, the mouth may be affected by non-healing sores (<a href="/wiki/Aphthous_ulcer" id="w">aphthous ulcers</a>). Rarely, the <a href="/wiki/Esophagus" id="w">esophagus</a>, and <a href="/wiki/Stomach" id="w">stomach</a> may be involved in Crohn&#39;s disease. These can cause symptoms including  difficulty swallowing (<a href="/wiki/Odynophagia" id="w">odynophagia</a>), upper abdominal pain, and vomiting.<sup id="_ref-14" class="reference"><a href="#_note-14" title="">[14]</a></sup></p>
<dl><dt>Systemic symptoms</dt></dl>
<p>Crohn&#39;s disease, like many other chronic, inflammatory diseases, can cause a variety of <a href="/wiki/B_symptoms" id="w">systemic symptoms</a>.<sup id="_ref-Hanauer_g" class="reference"><a href="#_note-Hanauer" title="">[1]</a></sup> Among children, <a href="/wiki/Growth_failure" id="w">growth failure</a> is common. Many children are first diagnosed with Crohn&#39;s disease based on <a href="/wiki/Failure_to_thrive" id="w">inability to maintain growth</a>.<sup id="_ref-Beattie_a" class="reference"><a href="#_note-Beattie" title="">[15]</a></sup>  As Crohn&#39;s disease may manifest at the time of the growth spurt in <a href="/wiki/Puberty" id="w">puberty</a>, up to 30% of children with Crohn&#39;s disease may have retardation of growth.<sup id="_ref-16" class="reference"><a href="#_note-16" title="">[16]</a></sup> Fever may also be present, though fevers greater than 38.5&#160;<a href="/wiki/Celsius" id="w">˚C</a> (101.3&#160;<a href="/wiki/Fahrenheit" id="w">˚F</a>) are uncommon unless there is a complication such as an <a href="/wiki/Abscess" id="w">abscess</a><sup id="_ref-Hanauer_h" class="reference"><a href="#_note-Hanauer" title="">[1]</a></sup> Among older individuals, Crohn&#39;s disease may manifest as weight loss. This is usually related to decreased food intake, since individuals with intestinal symptoms from Crohn&#39;s disease often feel better when they do not eat and might lose their appetite.<sup id="_ref-Beattie_b" class="reference"><a href="#_note-Beattie" title="">[15]</a></sup>  People with extensive <a href="/wiki/Small_intestine" id="w">small intestine</a> disease may also have <a href="/wiki/Malabsorption" id="w">malabsorption</a> of <a href="/wiki/Carbohydrate" id="w">carbohydrates</a> or <a href="/wiki/Lipid" id="w">lipids</a>, which can further exacerbate weight loss.<sup id="_ref-17" class="reference"><a href="#_note-17" title="">[17]</a></sup></p>
<dl><dt>Extraintestinal symptoms</dt></dl>
<p><div style="wigth:150px"><a class="internal" href="/wiki/Image:150px-Crohnie_sores_4.JPG" title="Erythema nodosum."><img src="http://en.wikipedia.org/wiki/150px-Crohnie_sores_4.JPG" alt="Erythema nodosum." title="Erythema nodosum." class="location-right type-thumb" width="150px" />
</a>
<div class="thumbcaption">Erythema nodosum.</div></div>

In addition to systemic and gastrointestinal involvement, Crohn&#39;s disease can affect many other organ systems.<sup id="_ref-Danese_a" class="reference"><a href="#_note-Danese" title="">[18]</a></sup> Inflammation of the interior portion of the eye, known as <a href="/wiki/Uveitis" id="w">uveitis</a>, can cause eye pain, especially when exposed to light (<a href="/wiki/Photophobia" id="w">photophobia</a>). Inflammation may also involve the white part of the eye (<a href="/wiki/Sclera" id="w">sclera</a>), a condition called <a href="/wiki/Scleritis" id="w">episcleritis</a>. Both episcleritis and uveitis can lead to loss of vision if untreated.</p>
<p>Crohn&#39;s disease is associated with a type of <a href="/wiki/Rheumatology" id="w">rheumatologic disease</a> known as <a href="/wiki/Spondyloarthropathy" id="w">seronegative spondyloarthropathy</a>. This group of diseases is characterized by inflammation of one or more <a href="/wiki/Joint" id="w">joints</a> (<a href="/wiki/Arthritis" id="w">arthritis</a>) or muscle insertions (<a href="/wiki/Enthesitis" id="w">enthesitis</a>). The arthritis can affect larger joints such as the knee or shoulder or may exclusively involve the small joints of the hand and feet. The arthritis may also involve the spine, leading to <a href="/wiki/Ankylosing_spondylitis" id="w">ankylosing spondylitis</a> if the entire spine is involved or simply <a href="/wiki/Sacroiliitis" id="w">sacroiliitis</a> if only the lower spine is involved. The symptoms of arthritis include painful, warm, swollen, stiff <a href="/wiki/Arthralgia" id="w">joints</a> and loss of joint mobility or function.</p>
<p>Crohn&#39;s disease may also involve the skin, blood, and <a href="/wiki/Endocrine_system" id="w">endocrine system</a>. One type of skin manifestation, <a href="/wiki/Erythema_nodosum" id="w">erythema nodosum</a>, presents as red nodules usually appearing on the shins. Erythema nodosum is due to inflammation of the underlying subcutaneous tissue and is characterized by septal <a href="/wiki/Panniculitis" id="w">panniculitis</a>. Another skin lesion, <a href="/wiki/Pyoderma_gangrenosum" id="w">pyoderma gangrenosum</a>, is typically a painful ulcerating nodule. Crohn&#39;s disease also increases the risk of blood clots; painful swelling of the lower legs can be a sign of <a href="/wiki/Deep_venous_thrombosis" id="w">deep venous thrombosis</a>, while difficulty breathing may be a result of <a href="/wiki/Pulmonary_embolism" id="w">pulmonary embolism</a>. <a href="/wiki/Autoimmune_hemolytic_anemia" id="w">Autoimmune hemolytic anemia</a>, a condition in which the immune system attacks the <a href="/wiki/Red_blood_cells" id="w">red blood cells</a>, is also more common in Crohn&#39;s disease and may cause fatigue, pallor, and other symptoms common in <a href="/wiki/Anemia" id="w">anemia</a>. <a href="/wiki/Clubbing" id="w">Clubbing</a>, a deformity of the ends of the fingers, may also be a result of Crohn&#39;s disease. Finally, Crohn&#39;s disease may cause <a href="/wiki/Osteoporosis" id="w">osteoporosis</a>, or thinning of the bones. Individuals with osteoporosis are at increased risk of <a href="/wiki/Bone_fracture" id="w">bone fractures</a>.<sup id="_ref-Bernstein_b" class="reference"><a href="#_note-Bernstein" title="">[4]</a></sup></p>
<p>Crohn&#39;s disease can also cause neurological complications (reportedly in up to 15% of patients).<sup id="_ref-pro_a" class="reference"><a href="#_note-pro" title="">[19]</a></sup> The most common of these are seizures, stroke, myopathy, peripheral neuropathy, headache and depression.<sup id="_ref-pro_b" class="reference"><a href="#_note-pro" title="">[19]</a></sup></p>
<p>Crohn&#39;s patients often also have issues with <a href="/wiki/Small_bowel_bacterial_overgrowth_syndrome" id="w">Small bowel bacterial overgrowth syndrome</a>, which has similar symptoms.</p>
<dl><dt>Complications</dt></dl>
<p><div style="wigth:200px"><a class="internal" href="/wiki/Image:200px-Colorectal_cancer_endo_2.jpg" title="[[Colonoscopy|Endoscopic]] image of &#39;&#39;&#39;colon cancer&#39;&#39;&#39; identified in the sigmoid [[colon (anatomy)]] on screening [[colonoscopy]] for Crohn&#39;s disease."><img src="http://en.wikipedia.org/wiki/200px-Colorectal_cancer_endo_2.jpg" alt="[[Colonoscopy|Endoscopic]] image of &#39;&#39;&#39;colon cancer&#39;&#39;&#39; identified in the sigmoid [[colon (anatomy)]] on screening [[colonoscopy]] for Crohn&#39;s disease." title="[[Colonoscopy|Endoscopic]] image of &#39;&#39;&#39;colon cancer&#39;&#39;&#39; identified in the sigmoid [[colon (anatomy)]] on screening [[colonoscopy]] for Crohn&#39;s disease." class="location-right type-thumb" width="200px" />
</a>
<div class="thumbcaption"><a href="/wiki/Colonoscopy" id="w">Endoscopic</a> image of <b>colon cancer</b> identified in the sigmoid <a href="/wiki/Colon_(anatomy)" id="w">colon (anatomy)</a> on screening <a href="/wiki/Colonoscopy" id="w">colonoscopy</a> for Crohn&#39;s disease.</div></div>
  
Crohn&#39;s disease can lead to several mechanical complications within the intestines, including obstruction, fistulae, and abscesses. Obstruction typically occurs from strictures or adhesions which narrow the lumen, blocking the passage of the intestinal contents. Fistulae can develop between two loops of bowel, between the bowel and bladder, between the bowel and vagina, and between the bowel and skin. Abscesses are walled off collections of <a href="/wiki/Infection" id="w">infection</a>, which can occur in the <a href="/wiki/Abdomen" id="w">abdomen</a> or in the <a href="http://en.wiktionary.org/wiki/Perianal">perianal</a> area in Crohn&#39;s disease sufferers.</p>
<p>Crohn&#39;s disease also increases the risk of cancer in the area of inflammation. For example, individuals with Crohn&#39;s disease involving the <a href="/wiki/Small_bowel" id="w">small bowel</a> are at higher risk for <a href="/wiki/Small_intestinal_cancer" id="w">small intestinal cancer</a>. Similarly, people with Crohn&#39;s colitis have a <a href="/wiki/Relative_risk" id="w">relative risk</a> of 5.6 for developing <a href="/wiki/Colon_cancer" id="w">colon cancer</a>.<sup id="_ref-20" class="reference"><a href="#_note-20" title="">[20]</a></sup> Screening for colon cancer with <a href="/wiki/Colonoscopy" id="w">colonoscopy</a> is recommended for anyone who has had Crohn&#39;s colitis for eight years, or more.<sup id="_ref-21" class="reference"><a href="#_note-21" title="">[21]</a></sup></p>
<p>Individuals with Crohn&#39;s disease are at risk of <a href="/wiki/Malnutrition" id="w">malnutrition</a> for many reasons, including decreased food intake and <a href="/wiki/Malabsorption" id="w">malabsorption</a>. The risk increases following resection of the <a href="/wiki/Small_bowel" id="w">small bowel</a>. Such individuals may require oral supplements to increase their caloric intake, or in severe cases, <a href="/wiki/Total_parenteral_nutrition" id="w">total parenteral nutrition</a> (TPN). Most people with moderate or severe Crohn&#39;s disease are referred to a <a href="/wiki/Dietitian" id="w">dietitian</a> for assistance in nutrition.<sup id="_ref-22" class="reference"><a href="#_note-22" title="">[22]</a></sup></p>
<a id="Cause" name="Cause"></a><h1>Cause</h1>

<p><div style="wigth:200px"><a class="internal" href="/wiki/Image:200px-NOD2_CARD15.svg.png" title="Schematic of NOD2 CARD15 gene, which is associated with certain disease patterns in Crohn&#39;s disease"><img src="http://en.wikipedia.org/wiki/200px-NOD2_CARD15.svg.png" alt="Schematic of NOD2 CARD15 gene, which is associated with certain disease patterns in Crohn&#39;s disease" title="Schematic of NOD2 CARD15 gene, which is associated with certain disease patterns in Crohn&#39;s disease" class="location-right type-thumb" width="200px" />
</a>
<div class="thumbcaption">Schematic of NOD2 CARD15 gene, which is associated with certain disease patterns in Crohn&#39;s disease</div></div>
</p>
<p>The exact cause of Crohn&#39;s disease is unknown. However, genetic and environmental factors have been invoked in the <a href="/wiki/Pathogenesis" id="w">pathogenesis</a> of the disease. Research has indicated that Crohn&#39;s disease has a strong genetic link. <sup id="_ref-23" class="reference"><a href="#_note-23" title="">[23]</a></sup> The disease runs in families and those with a sibling with the disease are 30 times more likely to develop it than the normal population. Ethnic background is also a risk factor. Until very recently, whites and European Jews accounted for the vast majority of the cases in the United States, and in most industrialized countries, this demographic is still true.  </p>
<p><a href="/wiki/Mutation" id="w">Mutations</a> in the <a href="/wiki/CARD15" id="w">CARD15</a> gene (also known as the NOD2 <a href="/wiki/Gene" id="w">gene</a>) are associated with Crohn&#39;s disease<sup id="_ref-24" class="reference"><a href="#_note-24" title="">[24]</a></sup> and with susceptibility to certain phenotypes of disease location and activity.<sup id="_ref-25" class="reference"><a href="#_note-25" title="">[25]</a></sup> In earlier studies, only two genes were linked to Crohn&#39;s, but scientists now believe there are over eight genes that show genetics play a crucial role in the disease.</p>
<p>A handful of cases of Crohn&#39;s Disease cases were reported at the turn of the 20th century, but since then, the disease has continued to increase in prevalence dramatically. Some argue that this increase has been the result of a genetic shift in the population caused by conditions favoring individuals carrying the genes linked with the disease. These conditions could be a lower infant mortality rate or better health care in the nations that have the highest incidence of disease (industrialized nations).   </p>
<p>Others argue that Crohn&#39;s Disease is caused by a combination of environmental and genetic factors. Many environmental factors have also been hypothesized as causes or risk factors for Crohn&#39;s disease. Proven environmental risk factors include living in an industrialized country, smoking, and living in an urban area. Diets high in sweet, <a href="/wiki/Fat" id="w">fatty</a> or <a href="/wiki/Food_processing" id="w">refined foods</a> may also play a role. A retrospective Japanese study found that those diagnosed with Crohn&#39;s disease had higher intakes of sugar, fat, fish and shellfish than controls prior to diagnosis.<sup id="_ref-26" class="reference"><a href="#_note-26" title="">[26]</a></sup> A similar study in Israel also found higher intakes of fats (especially chemically modified fats) and <a href="/wiki/Sucrose" id="w">sucrose</a>, with lower intakes of <a href="/wiki/Fructose" id="w">fructose</a> and fruits, water, <a href="/wiki/Potassium" id="w">potassium</a>, <a href="/wiki/Magnesium" id="w">magnesium</a> and vitamin C in the diets of Crohn&#39;s disease sufferers before diagnosis,<sup id="_ref-27" class="reference"><a href="#_note-27" title="">[27]</a></sup> and cites three large European studies in which sugar intake was significantly increased in people with Crohn&#39;s disease compared with controls. Certain chemicals in the diet, known as microparticles, are also hypothesized as a risk factor for the disease, as well as a poor imbalance of omega-6 to healthy omega-3 fatty acids that emerging research shows helps to improve all types of inflammatory disease. The most common forms of microparticles include titanium dioxide, aluminosilicates, anatase, calcium phosphate, and soil residue. These substances are ubiquitous in processed food and most toothpastes and lip glosses. Soil residue is found on fresh fruits and vegetables unless carefully removed. </p>
<p><a href="/wiki/Tobacco_smoking" id="w">Smoking</a> has been shown to increase the risk of the return of active disease, or &#34;flares&#34;.<sup id="_ref-28" class="reference"><a href="#_note-28" title="">[28]</a></sup>
The introduction of <a href="/wiki/Hormonal_contraception" id="w">hormonal contraception</a> in the United States in the 1960&#39;s is linked with a dramatic increase in the incidence rate of Crohn&#39;s disease. Although a causal linkage has not been effectively shown, there remain fears that these drugs work on the digestive system in similar ways to smoking.<sup id="_ref-29" class="reference"><a href="#_note-29" title="">[29]</a></sup></p>
<p>Additionally, many in the scientific community believe that early childhood exposure to illness is necessary to the creation of a proper immune system for those with the genetic suseptibility for Crohn&#39;s Disease. Like Polio, higher incidences of Crohn&#39;s Disease are associated with cleaner living conditions. Throughout the early and mid-20th century in the United States, the disease was strongly associated with upper-class populations, and today the disease does not yet exist in the many Third World countries, despite the fact that it occurs in all races. CD is also associated with first born and single children (because  they would have less exposure to childhood illness from siblings) and in populations that have low incidences of gastric cancer. Gastric cancer is most often caused by the bacterium Helicobacter pylori that flourishes in cramped and unsanitary conditions.&#60;<a class="externallink" href="http://findarticles.com/p/articles/mi_m0999/is_7271_321/ai_67708495/" rel="nofollow" title="http://findarticles.com/p/articles/mi_m0999/is_7271_321/ai_67708495/">http://findarticles.com/p/articles/mi_m0999/is_7271_321/ai_67708495/</a>&#62;      </p>
<p>Abnormalities in the immune system have often been invoked as being causes of Crohn&#39;s disease. It has been hypothesized that Crohn&#39;s disease involves augmentation of the <a href="/wiki/T_helper_cell#Th1.2FTh2 Model for helper T cells" id="w">T&#60;sub&#62;h&#60;/sub&#62;1</a> of <a href="/wiki/Cytokine" id="w">cytokine</a> response in inflammation.<sup id="_ref-30" class="reference"><a href="#_note-30" title="">[30]</a></sup> The most recent gene to be implicated in Crohn&#39;s disease is ATG16L1, which may reduce the effectiveness of <a href="/wiki/Autophagy" id="w">autophagy</a>, and hinder the body&#39;s ability to attack invasive bacteria.<sup id="_ref-31" class="reference"><a href="#_note-31" title="">[31]</a></sup></p>
<p>A variety of pathogenic bacteria were initially suspected of being causative agents of Crohn&#39;s disease.  However, the current consensus is that a variety of microorganisms are simply taking advantage of their host&#39;s weakened mucosal layer and inability to clear bacteria from the intestinal walls, both symptoms of the disease.  <sup id="_ref-32" class="reference"><a href="#_note-32" title="">[32]</a></sup>  Some studies have linked <a href="/wiki/Mycobacterium_avium_subspecies_paratuberculosis" id="w">&#39;&#39;Mycobacterium avium&#39;&#39; subsp. &#39;&#39;paratuberculosis&#39;&#39;</a> to Crohn&#39;s disease, in part because it causes a very similar disease, <a href="/wiki/Johne%26%2339%3Bs_disease" id="w">Johne&#39;s disease</a>, in cattle. <sup id="_ref-33" class="reference"><a href="#_note-33" title="">[33]</a></sup>
The <a href="/wiki/Mannose" id="w">mannose</a> bearing antigens, mannins, from yeast may also elicit pathogenic <a href="/wiki/Anti_saccharomyces_cerevisiae_antibodies" id="w">anti saccharomyces cerevisiae antibodies</a>.<sup id="_ref-pmid1398231_a" class="reference"><a href="#_note-pmid1398231" title="">[34]</a></sup>  Newer studies have linked specific strains of enteroadherent <i><a href="/wiki/E._coli" id="w">E. coli</a></i> to the disease but failed to find evidence of contributions by other species. 
<sup id="_ref-35" class="reference"><a href="#_note-35" title="">[35]</a></sup></p>
<a id="Pathophysiology" name="Pathophysiology"></a><h1>Pathophysiology</h1>

<p><div style="wigth:120px"><a class="internal" href="/wiki/Image:120px-Crohn's_transmural_path.jpg" title="H and E section of [[colectomy]] showing transmural inflammation."><img src="http://en.wikipedia.org/wiki/120px-Crohn's_transmural_path.jpg" alt="H and E section of [[colectomy]] showing transmural inflammation." title="H and E section of [[colectomy]] showing transmural inflammation." class="location-right type-thumb" width="120px" />
</a>
<div class="thumbcaption">H and E section of <a href="/wiki/Colectomy" id="w">colectomy</a> showing transmural inflammation.</div></div>
</p>
<p>At the time of <a href="/wiki/Colonoscopy" id="w">colonoscopy</a>, <a href="/wiki/Biopsy" id="w">biopsies</a> of the colon are often taken in order to confirm the diagnosis.  There are certain characteristic features of the <a href="/wiki/Pathology" id="w">pathology</a> seen that point toward Crohn&#39;s disease. Crohn&#39;s disease shows a transmural pattern of <a href="/wiki/Inflammation" id="w">inflammation</a>, meaning that the inflammation may span the entire depth of the intestinal wall.<sup id="_ref-Hanauer_i" class="reference"><a href="#_note-Hanauer" title="">[1]</a></sup> Grossly, <a href="/wiki/Ulcer" id="w">ulceration</a> is an outcome seen in highly active disease.  There is usually an abrupt transition between unaffected tissue and the ulcer. Under a microscope, biopsies of the affected colon may show <a href="/wiki/Mucosa" id="w">mucosal</a> inflammation. Transmural inflammation results in formation of <a href="/wiki/Lymphoid_aggregate" id="w">lymphoid aggregates</a> throughout the wall of the colon. This inflammation is characterized by focal infiltration of <a href="/wiki/Neutrophils" id="w">neutrophils</a>, a type of inflammatory cell, into the <a href="/wiki/Epithelium" id="w">epithelium</a>. This typically occurs in the area overlying <a href="/wiki/Lymphoid_tissue" id="w">lymphoid</a> aggregates. These neutrophils, along with <a href="/wiki/Lymphocyte" id="w">mononuclear cells</a>, may infiltrate into the <a href="/wiki/Crypts_of_Lieberkuhn" id="w">crypts</a> leading to inflammation (crypititis) or abscess (crypt abscess).  <a href="/wiki/Granuloma" id="w">Granulomas</a>, aggregates of <a href="/wiki/Macrophage" id="w">macrophage</a> derivatives known as giant cells, are found in 50% of cases and are most specific for Crohn&#39;s disease. The granulomas of Crohn&#39;s disease do not show &#34;caseation&#34;, a cheese-like appearance on microscopic examination that is characteristic of granulomas associated with infections such as <a href="/wiki/Tuberculosis" id="w">tuberculosis</a>. Biopsies may also show chronic mucosal damage as evidenced by blunting of the intestinal <a href="/wiki/Villus" id="w">villi</a>, atypical branching of the crypts, and change in the tissue type (<a href="/wiki/Metaplasia" id="w">metaplasia</a>). One example of such metaplasia, <i>Paneth cell metaplasia</i>, involves development of Paneth cells (typically found in the small intestine) in other parts of the gastrointestinal system.<sup id="_ref-Robbins_a" class="reference"><a href="#_note-Robbins" title="">[36]</a></sup>
{{sectstub}} </p>
<a id="Diagnosis" name="Diagnosis"></a><h1>Diagnosis</h1>

<p><div style="wigth:150px"><a class="internal" href="/wiki/Image:150px-CD_colitis.jpg" title="[[Colonoscopy|Endoscopic]] image of Crohn&#39;s colitis showing deep ulceration."><img src="http://en.wikipedia.org/wiki/150px-CD_colitis.jpg" alt="[[Colonoscopy|Endoscopic]] image of Crohn&#39;s colitis showing deep ulceration." title="[[Colonoscopy|Endoscopic]] image of Crohn&#39;s colitis showing deep ulceration." class="location-right type-thumb" width="150px" />
</a>
<div class="thumbcaption"><a href="/wiki/Colonoscopy" id="w">Endoscopic</a> image of Crohn&#39;s colitis showing deep ulceration.</div></div>

<div style="wigth:150px"><a class="internal" href="/wiki/Image:150px-CT_scan_gastric_CD.jpg" title="[[CT scan]] showing Crohn&#39;s disease in the fundus of the [[stomach]]"><img src="http://en.wikipedia.org/wiki/150px-CT_scan_gastric_CD.jpg" alt="[[CT scan]] showing Crohn&#39;s disease in the fundus of the [[stomach]]" title="[[CT scan]] showing Crohn&#39;s disease in the fundus of the [[stomach]]" class="location-right type-thumb" width="150px" />
</a>
<div class="thumbcaption"><a href="/wiki/CT_scan" id="w">CT scan</a> showing Crohn&#39;s disease in the fundus of the <a href="/wiki/Stomach" id="w">stomach</a></div></div>

<div style="wigth:150px"><a class="internal" href="/wiki/Image:150px-CD_colitis_2.jpg" title="Crohn&#39;s disease can mimic [[ulcerative colitis]] on endoscopy.  This [[Colonoscopy|endoscopic]] image is of Crohn&#39;s colitis showing diffuse loss of [[mucosa]]l architecture, [[friable|friability]] of mucosa in sigmoid colon and exudate on wall, all of which can be found with ulcerative colitis."><img src="http://en.wikipedia.org/wiki/150px-CD_colitis_2.jpg" alt="Crohn&#39;s disease can mimic [[ulcerative colitis]] on endoscopy.  This [[Colonoscopy|endoscopic]] image is of Crohn&#39;s colitis showing diffuse loss of [[mucosa]]l architecture, [[friable|friability]] of mucosa in sigmoid colon and exudate on wall, all of which can be found with ulcerative colitis." title="Crohn&#39;s disease can mimic [[ulcerative colitis]] on endoscopy.  This [[Colonoscopy|endoscopic]] image is of Crohn&#39;s colitis showing diffuse loss of [[mucosa]]l architecture, [[friable|friability]] of mucosa in sigmoid colon and exudate on wall, all of which can be found with ulcerative colitis." class="location-right type-thumb" width="150px" />
</a>
<div class="thumbcaption">Crohn&#39;s disease can mimic <a href="/wiki/Ulcerative_colitis" id="w">ulcerative colitis</a> on endoscopy.  This <a href="/wiki/Colonoscopy" id="w">endoscopic</a> image is of Crohn&#39;s colitis showing diffuse loss of <a href="/wiki/Mucosa" id="w">mucosal</a> architecture, <a href="/wiki/Friable" id="w">friability</a> of mucosa in sigmoid colon and exudate on wall, all of which can be found with ulcerative colitis.</div></div>
</p>
<p>The diagnosis of Crohn&#39;s disease can sometimes be challenging,<sup id="_ref-Pimentel_b" class="reference"><a href="#_note-Pimentel" title="">[10]</a></sup> and a number of tests are often required to assist the physician in making the diagnosis.<sup id="_ref-emed_f" class="reference"><a href="#_note-emed" title="">[5]</a></sup>  Sometimes even with all the tests the Crohn&#39;s does not show itself.  A colonoscopy has about a 70% chance of showing the disease and the rest of the tests go down in percentage.  Disease in the small bowel can not be seen through some of the regular tests; for example, a colonoscopy can&#39;t get there.</p>
<dl><dt>Endoscopy</dt></dl>
<p>A <a href="/wiki/Colonoscopy" id="w">colonoscopy</a> is the best test for making the diagnosis of Crohn&#39;s disease as it allows direct visualization of the colon and the <a href="/wiki/Terminal_ileum" id="w">terminal ileum</a>, identifying the pattern of disease involvement. Occasionally, the colonoscope can travel past the terminal ileum but it varies from patient to patient. During the procedure, the <a href="/wiki/Gastroenterologist" id="w">gastroenterologist</a> can also perform a <a href="/wiki/Biopsy" id="w">biopsy</a>, taking small samples of tissue for laboratory analysis which may help confirm a diagnosis.  As 30% of Crohn&#39;s disease involves only the ileum,<sup id="_ref-Hanauer_j" class="reference"><a href="#_note-Hanauer" title="">[1]</a></sup> <a href="/wiki/Cannula" id="w">cannulation</a> of the terminal ileum is required in making the diagnosis. Finding a patchy distribution of disease, with involvement of the colon or ileum but not the <a href="/wiki/Rectum" id="w">rectum</a>, is suggestive of Crohn&#39;s disease, as are other endoscopic stigmata.<sup id="_ref-37" class="reference"><a href="#_note-37" title="">[37]</a></sup></p>
<p><a href="/wiki/Wireless_capsule_endoscopy" id="w">Wireless capsule endoscopy</a> is a technique where a small capsule with a built-in camera is swallowed, the camera takes serial pictures of the entire gastrointestinal tract and is passed in the patient&#39;s faeces.  It has been used in the search for Crohn&#39;s disease in the small bowel, which cannot be reached with colonoscopy or gastroscopy.<sup id="_ref-Hara2006_a" class="reference"><a href="#_note-Hara2006" title="">[38]</a></sup>The utility of capsule endoscopy for this, however, is still uncertain.<sup id="_ref-39" class="reference"><a href="#_note-39" title="">[39]</a></sup></p>
<dl><dt>Radiologic tests</dt></dl>
<p>A <a href="/wiki/Barium_follow-through" id="w">small bowel follow-through</a> may suggest the diagnosis of Crohn&#39;s disease and is useful when the disease involves only the small intestine. Because colonoscopy and <a href="/wiki/Esophagogastroduodenoscopy" id="w">gastroscopy</a> allow direct visualization of only the terminal ileum and beginning of the <a href="/wiki/Duodenum" id="w">duodenum</a>, they cannot be used to evaluate the remainder of the small intestine. As a result, a <a href="/wiki/Barium_follow-through" id="w">barium follow-through</a> x-ray, wherein <a href="/wiki/Barium_sulfate" id="w">barium sulfate</a> suspension is ingested and <a href="/wiki/Fluoroscopy" id="w">fluoroscopic</a> images of the bowel are taken over time, is useful for looking for inflammation and narrowing of the small bowel.<sup id="_ref-Hara2006_b" class="reference"><a href="#_note-Hara2006" title="">[38]</a></sup><sup id="_ref-40" class="reference"><a href="#_note-40" title="">[40]</a></sup> Barium enemas, in which barium is inserted into the rectum and fluoroscopy used to image the bowel, are rarely used in the work-up of Crohn&#39;s disease due to the advent of colonoscopy. They remain useful for identifying anatomical abnormalities when strictures of the colon are too small for a colonoscope to pass through, or in the detection of colonic fistulae.<sup id="_ref-41" class="reference"><a href="#_note-41" title="">[41]</a></sup></p>
<p><a href="/wiki/Computed_tomography" id="w">CT</a> and <a href="/wiki/MRI" id="w">MRI</a> scans are useful for evaluating the small bowel with <a href="/wiki/Enteroclysis" id="w">enteroclysis</a> protocols.<sup id="_ref-42" class="reference"><a href="#_note-42" title="">[42]</a></sup>They are additionally useful for looking for intra-abdominal complications of Crohn&#39;s disease such as <a href="/wiki/Abscess" id="w">abscesses</a>, small bowel obstruction, or fistulae.<sup id="_ref-43" class="reference"><a href="#_note-43" title="">[43]</a></sup> <a href="/wiki/Magnetic_resonance_imaging" id="w">Magnetic resonance imaging</a> (MRI) are another option for imaging the <a href="/wiki/Small_bowel" id="w">small bowel</a> as well as looking for complications, though it is more expensive and less readily available<sup id="_ref-44" class="reference"><a href="#_note-44" title="">[44]</a></sup></p>
<dl><dt>Blood tests</dt></dl>
<p>A <a href="/wiki/Complete_blood_count" id="w">complete blood count</a> may reveal <a href="/wiki/Anemia" id="w">anemia</a>, which may be caused either by blood loss or <a href="/wiki/Cyanocobalamin" id="w">vitamin B{{ssub}}</a> deficiency. The latter may be seen with ileitis because vitamin B{{ssub}} is absorbed in the <a href="/wiki/Ileum" id="w">ileum</a>.<sup id="_ref-Goh_a" class="reference"><a href="#_note-Goh" title="">[45]</a></sup> <a href="/wiki/Erythrocyte_sedimentation_rate" id="w">Erythrocyte sedimentation rate</a>, or ESR, and <a href="/wiki/C-reactive_protein" id="w">C-reactive protein</a> measurements can also be useful to gauge the degree of inflammation.<sup id="_ref-46" class="reference"><a href="#_note-46" title="">[46]</a></sup> It is also true in patient with ilectomy done in response to the complication. Another cause of anaemia is anaemia of chronic disease, characterized by its microcytic and hypochromic anaemia. There are reasons in anaemia, including medication in treatment of inflammatory bowel disease like azathioprine can lead to cytopenia and sulfasalazine can also result in folate malabsorption, etc. Testing for anti-<i><a href="/wiki/Saccharomyces_cerevisiae" id="w">Saccharomyces cerevisiae</a></i> antibodies (ASCA) and <a href="/wiki/Anti-neutrophil_cytoplasmic_antibody" id="w">anti-neutrophil cytoplasmic antibodies</a> (ANCA) has been evaluated to identify inflammatory diseases of the intestine<sup id="_ref-47" class="reference"><a href="#_note-47" title="">[47]</a></sup> and to differentiate Crohn&#39;s disease from ulcerative colitis.<sup id="_ref-48" class="reference"><a href="#_note-48" title="">[48]</a></sup></p>
<a id="Comparison_with_ulcerative_colitis" name="Comparison_with_ulcerative_colitis"></a><h2>Comparison with ulcerative colitis</h2>
<p>The most common disease that mimics the symptoms of Crohn&#39;s disease is <a href="/wiki/Ulcerative_colitis" id="w">ulcerative colitis</a>, as both are inflammatory bowel diseases that can affect the <a href="/wiki/Colon_(anatomy)" id="w">colon</a> with similar symptoms. It is important to differentiate these diseases, since the course of the diseases and treatments may be different. In some cases, however, it may not be possible to tell the difference, in which case the disease is classified as <b>indeterminate colitis</b>.<sup id="_ref-Podolsky_c" class="reference"><a href="#_note-Podolsky" title="">[7]</a></sup><sup id="_ref-Hanauer_k" class="reference"><a href="#_note-Hanauer" title="">[1]</a></sup><sup id="_ref-emed_g" class="reference"><a href="#_note-emed" title="">[5]</a></sup></p>

<div style="page-break-inside:	avoid;">
<table cellpadding="1" class="prettytable" style="text-align:left">
<caption><b>Comparisons of various factors in Crohn&#39;s disease and ulcerative colitis</b></caption>
<tr>
<th />
<th>Crohn&#39;s disease </th>
<th>Ulcerative colitis </th></tr>
<tr>
<td><a href="/wiki/Terminal_ileum" id="w">Terminal ileum</a> involvement </td>
<td>Commonly </td>
<td>Seldom</td></tr>
<tr>
<td>Colon involvement </td>
<td>Usually </td>
<td>Always </td></tr>
<tr>
<td>Rectum involvement </td>
<td>Seldom </td>
<td>Usually<sup id="_ref-Kornbluth-Sachar2004_a" class="reference"><a href="#_note-Kornbluth-Sachar2004" title="">[49]</a></sup> </td></tr>
<tr>
<td>Involvement around the <a href="/wiki/Anus" id="w">anus</a> </td>
<td>Common<sup id="_ref-HanauerCrohns_a" class="reference"><a href="#_note-HanauerCrohns" title="">[50]</a></sup>
 </td>
<td>Seldom </td></tr>
<tr>
<td>Bile duct involvement </td>
<td>No increase in rate of <a href="/wiki/Primary_sclerosing_cholangitis" id="w">primary sclerosing cholangitis</a>  </td>
<td>Higher rate<sup id="_ref-51" class="reference"><a href="#_note-51" title="">[51]</a></sup></td></tr>
<tr>
<td>Distribution of Disease </td>
<td>Patchy areas of inflammation </td>
<td>Continuous area of inflammation<sup id="_ref-Kornbluth-Sachar2004_b" class="reference"><a href="#_note-Kornbluth-Sachar2004" title="">[49]</a></sup> </td></tr>
<tr>
<td>Endoscopy </td>
<td>Deep geographic and serpiginous (snake-like) <a href="/wiki/Ulcer" id="w">ulcers</a>
 </td>
<td>Continuous ulcer </td></tr>
<tr>
<td>Depth of inflammation </td>
<td>May be transmural, deep into tissues<sup id="_ref-HanauerCrohns_b" class="reference"><a href="#_note-HanauerCrohns" title="">[50]</a></sup><sup id="_ref-Hanauer_l" class="reference"><a href="#_note-Hanauer" title="">[1]</a></sup> 
 </td>
<td>Shallow, mucosal </td></tr>
<tr>
<td><a href="/wiki/Fistula" id="w">Fistulae</a> </td>
<td>Common<sup id="_ref-HanauerCrohns_c" class="reference"><a href="#_note-HanauerCrohns" title="">[50]</a></sup>
 </td>
<td>Seldom </td></tr>
<tr>
<td><a href="/wiki/Stenosis" id="w">Stenosis</a> </td>
<td>Common </td>
<td>Seldom</td></tr>
<tr>
<td><a href="/wiki/Autoimmunity" id="w">Autoimmune disease</a> </td>
<td>Widely regarded as an autoimmune disease </td>
<td>No consensus</td></tr>
<tr>
<td><a href="/wiki/Cytokine" id="w">Cytokine</a> response </td>
<td>Associated with <a href="/wiki/T_helper_cell#Th1.2FTh2 Model for helper T cells" id="w">T&#60;sub&#62;h&#60;/sub&#62;1</a> </td>
<td>Vaguely associated with T<sub>h</sub>2</td></tr>
<tr>
<td><a href="/wiki/Granuloma" id="w">Granulomas</a> on biopsy </td>
<td>Can have granulomas<sup id="_ref-HanauerCrohns_d" class="reference"><a href="#_note-HanauerCrohns" title="">[50]</a></sup>
 </td>
<td>Granulomas uncommon<sup id="_ref-Kornbluth-Sachar2004_c" class="reference"><a href="#_note-Kornbluth-Sachar2004" title="">[49]</a></sup></td></tr>
<tr>
<td>Surgical cure </td>
<td>Often returns following removal of affected part </td>
<td>Usually cured by removal of colon</td></tr>
<tr>
<td><a href="/wiki/Tobacco_smoking" id="w">Smoking</a> </td>
<td>Higher risk for smokers </td>
<td>Lower risk for smokers<sup id="_ref-Kornbluth-Sachar2004_d" class="reference"><a href="#_note-Kornbluth-Sachar2004" title="">[49]</a></sup></td></tr></table></div>

<a id="Treatment" name="Treatment"></a><h1>Treatment</h1>

<p>{{main}}
Treatment is only needed for people exhibiting symptoms. The therapeutic approach to Crohn&#39;s disease is sequential: to treat <a href="/wiki/Acute_(medical)" id="w">acute</a> disease and then to maintain <a href="/wiki/Remission" id="w">remission</a>. Treatment initially involves the use of medications to treat any infection and to reduce inflammation. This usually involves the use of aminosalicylate anti-inflammatory drugs and corticosteroids, and may include antibiotics. </p>
<p>Once remission is induced, the goal of treatment becomes maintaining remission and avoiding flares. Because of side-effects, the prolonged use of corticosteroids must be avoided. Although some people are able to maintain remission with aminosalicylates alone, many require immunosuppressive drugs.<sup id="_ref-HanauerCrohns_e" class="reference"><a href="#_note-HanauerCrohns" title="">[50]</a></sup></p>
<p><a href="/wiki/Surgery" id="w">Surgery</a> may be required for complications such as obstructions, fistulas and/or abscesses, or if the disease does not respond to drugs within a reasonable time. For patients with an obstruction due to a stricture, two options for treatment are strictureplasty and resection of that portion of bowel.  According to a retrospective review at the Cleveland Clinic, there is no <a href="/wiki/Statistical_significance" id="w">statistical significance</a> between strictureplasty alone versus strictureplasty and resection specifically in cases of duodenal involvement. In these cases, re-operation rates were 31% and 27%, respectively, indicating that strictureplasty is a safe and effective treatment for selected patients with duodenal involvement.<sup id="_ref-pmid8918424_a" class="reference"><a href="#_note-pmid8918424" title="">[52]</a></sup></p>
<p>Recent studies using <a href="/wiki/Helminthic_therapy" id="w">Helminthic therapy</a> or <a href="/wiki/Hookworms" id="w">Hookworms</a> to treat Crohn&#39;s Disease and other (non-viral) auto-immune diseases seem to yield promising results.<sup id="_ref-53" class="reference"><a href="#_note-53" title="">[53]</a></sup><sup id="_ref-Daily Mail_a" class="reference"><a href="#_note-Daily Mail" title="">[54]</a></sup><sup id="_ref-55" class="reference"><a href="#_note-55" title="">[55]</a></sup></p>
<a id="Proprioceptive_Therapy" name="Proprioceptive_Therapy"></a><h1>Proprioceptive Therapy</h1>
<p>{{unreferencedsection}}
An Alternative Therapy in the treatment of Crohn&#39;s Disease:   
Rothbart Proprioceptive Therapy is claimed to reverse the anterior rotation of the hips, which in turn, is purported to decompress the intestines and colon. Waste products are then supposed to pass through the colon more quickly and efficiently.  Since 1950, there is not a single peer-reviewed publication demonstrating any effect of this therapy in Crohn&#39;s Disease.</p>
<a id="Prognosis" name="Prognosis"></a><h1>Prognosis</h1>

<p>Crohn&#39;s disease is a <a href="/wiki/Chronic_(medicine)" id="w">chronic</a> condition for which there is currently no cure. It is characterized by periods of improvement followed by episodes when symptoms flare up. With treatment, most people achieve a healthy height and weight, and the mortality rate for the disease is low. Crohn&#39;s disease is associated with an increased risk of small bowel and colorectal carcinoma.<sup id="_ref-Canavan_a" class="reference"><a href="#_note-Canavan" title="">[56]</a></sup></p>
<p>Crohn&#39;s cannot be cured by surgery, though surgery does happen with blockages, whether partial or a full blockage occurs.  After the first surgery, the Crohn&#39;s usually shows up at the site of the resection though it can appear in other locations.  After a resection, scar tissue builds up which causes strictures.  A stricture is when the intestines becomes too small to allow excrement to pass through easily which can lead to a blockage. After the first resection, another resection may be necessary within five years of the first surgery.</p>
<p>Many patients will have temporary stoma formations together with possible associated complications.{{Who}}</p>
<p>{{sectstub}} </p>
<a id="Epidemiology" name="Epidemiology"></a><h1>Epidemiology</h1>

<p>The incidence of Crohn&#39;s disease has been ascertained from population studies in <a href="/wiki/Norway" id="w">Norway</a> and the <a href="/wiki/United_States" id="w">United States</a> and is similar at 6 to 7.1:100,000.<sup id="_ref-Hiatt_a" class="reference"><a href="#_note-Hiatt" title="">[57]</a></sup><sup id="_ref-58" class="reference"><a href="#_note-58" title="">[58]</a></sup>  Crohn&#39;s disease is more common in northern countries, and shows a higher preponderance in northern areas of the same country.<sup id="_ref-59" class="reference"><a href="#_note-59" title="">[59]</a></sup> The incidence of Crohn&#39;s disease in <a href="/wiki/North_America" id="w">North America</a> is 6:100,000, and is thought to be similar in <a href="/wiki/Europe" id="w">Europe</a>, but lower in <a href="/wiki/Asia" id="w">Asia</a> and <a href="/wiki/Africa" id="w">Africa</a>.<sup id="_ref-Hiatt_b" class="reference"><a href="#_note-Hiatt" title="">[57]</a></sup> It also has a higher incidence in <a href="/wiki/Ashkenazi_Jews" id="w">Ashkenazi Jews</a>.<sup id="_ref-Podolsky_d" class="reference"><a href="#_note-Podolsky" title="">[7]</a></sup></p>
<p>Crohn&#39;s disease has a <a href="/wiki/Bimodal_distribution" id="w">bimodal distribution</a> in <a href="/wiki/Incidence_(epidemiology)" id="w">incidence</a> as a function of age: the disease tends to strike people in their teens and twenties, and people in their fifties through seventies.<sup id="_ref-Hanauer_m" class="reference"><a href="#_note-Hanauer" title="">[1]</a></sup><sup id="_ref-emed_h" class="reference"><a href="#_note-emed" title="">[5]</a></sup> It is rare in early childhood. There is no association with gender, social class or occupation.{{Fact}} Parents, siblings or children of people with Crohn&#39;s disease are 3 to 20 times more likely to develop the disease.<sup id="_ref-60" class="reference"><a href="#_note-60" title="">[60]</a></sup> Twin studies show a concordance of greater than 55% for Crohn&#39;s disease.<sup id="_ref-61" class="reference"><a href="#_note-61" title="">[61]</a></sup>
{{sectstub}}</p>
<a id="History" name="History"></a><h1>History</h1>
<p>Inflammatory bowel diseases were described by <a href="/wiki/Giovanni_Battista_Morgagni" id="w">Giovanni Battista Morgagni</a> (1682-1771), by Polish surgeon Antoni Leśniowski in 1904 (leading to the use of the eponym &#34;<b>Leśniowski-Crohn disease</b>&#34; in <a href="/wiki/Poland" id="w">Poland</a>) and by <a href="/wiki/Scotland" id="w">Scottish</a> physician T. Kennedy Dalziel in 1913.<sup id="_ref-62" class="reference"><a href="#_note-62" title="">[62]</a></sup></p>
<p><a href="/wiki/Burrill_Bernard_Crohn" id="w">Burrill Bernard Crohn</a>, an American gastroenterologist at <a href="/wiki/New_York_City" id="w">New York City</a>&#39;s <a href="/wiki/Mount_Sinai_Hospital%2C_New_York" id="w">Mount Sinai Hospital</a>, described fourteen cases in 1932, and submitted them to the <a href="/wiki/American_Medical_Association" id="w">American Medical Association</a> under the rubric of &#34;Terminal ileitis: A new clinical entity&#34;.  Later that year, he, along with colleagues Leon Ginzburg and Gordon Oppenheimer published the case series as &#34;Regional ileitis: a pathologic and clinical entity&#34;.<sup id="_ref-CrohnBB_b" class="reference"><a href="#_note-CrohnBB" title="">[2]</a></sup> </p>
<a id="See_also" name="See_also"></a><h1>See also</h1>

<ul>
<li><a href="/wiki/Small_bowel_bacterial_overgrowth_syndrome" id="w">Small bowel bacterial overgrowth syndrome</a></li></ul>
<p>{{Crohn&#39;s}}</p>
<a id="References" name="References"></a><h1> References </h1>
<p />
<div class="references-small" style="-moz-column-count:2; column-count:2;">
<p /><ol class="references">
<li id="_note-Hanauer">&uarr; <a href="#_ref-Hanauer_a" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Hanauer_b" title=""><sup><i><b>b</b></i></sup></a> <a href="#_ref-Hanauer_c" title=""><sup><i><b>c</b></i></sup></a> <a href="#_ref-Hanauer_d" title=""><sup><i><b>d</b></i></sup></a> <a href="#_ref-Hanauer_e" title=""><sup><i><b>e</b></i></sup></a> <a href="#_ref-Hanauer_f" title=""><sup><i><b>f</b></i></sup></a> <a href="#_ref-Hanauer_g" title=""><sup><i><b>g</b></i></sup></a> <a href="#_ref-Hanauer_h" title=""><sup><i><b>h</b></i></sup></a> <a href="#_ref-Hanauer_i" title=""><sup><i><b>i</b></i></sup></a> <a href="#_ref-Hanauer_j" title=""><sup><i><b>j</b></i></sup></a> <a href="#_ref-Hanauer_k" title=""><sup><i><b>k</b></i></sup></a> <a href="#_ref-Hanauer_l" title=""><sup><i><b>l</b></i></sup></a> <a href="#_ref-Hanauer_m" title=""><sup><i><b>m</b></i></sup></a> {{cite journal}}</li><li id="_note-CrohnBB">&uarr; <a href="#_ref-CrohnBB_a" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-CrohnBB_b" title=""><sup><i><b>b</b></i></sup></a> Crohn BB, Ginzburg L, Oppenheimer GD.  &#34;Regional ileitis: a pathologic and clinical entity.&#34;  <i>Mt Sinai J Med</i> 2000 May;67(3):263-8.  PMID 10828911</li><li id="_note-3"><b><a href="#_ref-3" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-Bernstein">&uarr; <a href="#_ref-Bernstein_a" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Bernstein_b" title=""><sup><i><b>b</b></i></sup></a> {{cite journal}}</li><li id="_note-emed">&uarr; <a href="#_ref-emed_a" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-emed_b" title=""><sup><i><b>b</b></i></sup></a> <a href="#_ref-emed_c" title=""><sup><i><b>c</b></i></sup></a> <a href="#_ref-emed_d" title=""><sup><i><b>d</b></i></sup></a> <a href="#_ref-emed_e" title=""><sup><i><b>e</b></i></sup></a> <a href="#_ref-emed_f" title=""><sup><i><b>f</b></i></sup></a> <a href="#_ref-emed_g" title=""><sup><i><b>g</b></i></sup></a> <a href="#_ref-emed_h" title=""><sup><i><b>h</b></i></sup></a> {{cite web}}</li><li id="_note-6"><b><a href="#_ref-6" title="">&uarr;</a></b> {{cite web}}</li><li id="_note-Podolsky">&uarr; <a href="#_ref-Podolsky_a" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Podolsky_b" title=""><sup><i><b>b</b></i></sup></a> <a href="#_ref-Podolsky_c" title=""><sup><i><b>c</b></i></sup></a> <a href="#_ref-Podolsky_d" title=""><sup><i><b>d</b></i></sup></a> {{Cite journal}}</li><li id="_note-Vienna">&uarr; <a href="#_ref-Vienna_a" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Vienna_b" title=""><sup><i><b>b</b></i></sup></a> {{cite journal}}</li><li id="_note-9"><b><a href="#_ref-9" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-Pimentel">&uarr; <a href="#_ref-Pimentel_a" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Pimentel_b" title=""><sup><i><b>b</b></i></sup></a> {{cite journal}}</li><li id="_note-11"><b><a href="#_ref-11" title="">&uarr;</a></b> <a class="externallink" href="http://www.emedicinehealth.com/crohn_disease/article_em.htm" rel="nofollow" title="http://www.emedicinehealth.com/crohn_disease/article_em.htm">Crohn Disease Overview</a></li><li id="_note-12"><b><a href="#_ref-12" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-13"><b><a href="#_ref-13" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-14"><b><a href="#_ref-14" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-Beattie">&uarr; <a href="#_ref-Beattie_a" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Beattie_b" title=""><sup><i><b>b</b></i></sup></a> </li><li id="_note-16"><b><a href="#_ref-16" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-17"><b><a href="#_ref-17" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-18"><b><a href="#_ref-18" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-pro">&uarr; <a href="#_ref-pro_a" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-pro_b" title=""><sup><i><b>b</b></i></sup></a> <a class="externallink" href="http://professionals.epilepsy.com/page/inflammatory_crohn.html" rel="nofollow" title="http://professionals.epilepsy.com/page/inflammatory_crohn.html">Crohn&#39;s disease</a>. professionals.epilepsy.com. Retrieved on <a href="/wiki/July_13" id="w">July 13</a>, <a href="/wiki/2007" id="w">2007</a>.</li><li id="_note-20"><b><a href="#_ref-20" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-21"><b><a href="#_ref-21" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-22"><b><a href="#_ref-22" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-23"><b><a href="#_ref-23" title="">&uarr;</a></b> <a class="externallink" href="http://www.ccfa.org/reuters/genelic" rel="nofollow" title="http://www.ccfa.org/reuters/genelic">link Crohn&#39;s disease has strong genetic link: study</a></li><li id="_note-24"><b><a href="#_ref-24" title="">&uarr;</a></b> Ogura Y, Bonen DK, Inohara N, <i>et al.</i>  A frameshift mutation in NOD2 associated with susceptibility to Crohn&#39;s disease.  <i>Nature</i>. 2001 May 31;411(6837):603-6.</li><li id="_note-25"><b><a href="#_ref-25" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-26"><b><a href="#_ref-26" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-27"><b><a href="#_ref-27" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-28"><b><a href="#_ref-28" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-29"><b><a href="#_ref-29" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-30"><b><a href="#_ref-30" title="">&uarr;</a></b> Cobrin GM, Abreu MT. Defects in mucosal immunity leading to Crohn&#39;s disease.  <i>Immunol Rev.</i> 2005 Aug;206:277-95.  PMID 16048555</li><li id="_note-31"><b><a href="#_ref-31" title="">&uarr;</a></b> Prescott NJ, Fisher SA, Franke A, Hampe J, Onnie CM, Soars D, Bagnall R, Mirza MM, Sanderson J, Forbes A, Mansfield JC, Lewis CM, Schreiber S, Mathew CG. A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn&#39;s disease and is independent of CARD15 and IBD5. <i>Gastroenterology.</i> 2007 May;132(5):1665-71. PMID: 17484864.</li><li id="_note-32"><b><a href="#_ref-32" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-33"><b><a href="#_ref-33" title="">&uarr;</a></b> Naser SA, Collins MT.  Debate on the lack of evidence of Mycobacterium avium subsp. paratuberculosis in Crohn&#39;s disease.  <i>Inflamm Bowel Dis.</i> 2005 Dec;11(12):1123.  PMID 16306778</li><li id="_note-34"><b><a href="#_ref-34" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-35"><b><a href="#_ref-35" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-36"><b><a href="#_ref-36" title="">&uarr;</a></b> Crawford JM.  &#34;The Gastrointestinal tract, Chapter 17&#34;.  In Cotran RS, Kumar V, Robbins SL. <i>Robbins Pathologic Basis of Disease: 5th Edition</i>.  W.B. Saunders and Company, Philadelphia, 1994.</li><li id="_note-37"><b><a href="#_ref-37" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-Hara2006">&uarr; <a href="#_ref-Hara2006_a" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Hara2006_b" title=""><sup><i><b>b</b></i></sup></a> </li><li id="_note-39"><b><a href="#_ref-39" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-40"><b><a href="#_ref-40" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-41"><b><a href="#_ref-41" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-42"><b><a href="#_ref-42" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-43"><b><a href="#_ref-43" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-44"><b><a href="#_ref-44" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-45"><b><a href="#_ref-45" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-46"><b><a href="#_ref-46" title="">&uarr;</a></b> {{cite journal}} Epub ahead of print</li><li id="_note-47"><b><a href="#_ref-47" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-48"><b><a href="#_ref-48" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-Kornbluth-Sachar2004">&uarr; <a href="#_ref-Kornbluth-Sachar2004_a" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Kornbluth-Sachar2004_b" title=""><sup><i><b>b</b></i></sup></a> <a href="#_ref-Kornbluth-Sachar2004_c" title=""><sup><i><b>c</b></i></sup></a> <a href="#_ref-Kornbluth-Sachar2004_d" title=""><sup><i><b>d</b></i></sup></a> {{cite journal}}</li><li id="_note-HanauerCrohns">&uarr; <a href="#_ref-HanauerCrohns_a" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-HanauerCrohns_b" title=""><sup><i><b>b</b></i></sup></a> <a href="#_ref-HanauerCrohns_c" title=""><sup><i><b>c</b></i></sup></a> <a href="#_ref-HanauerCrohns_d" title=""><sup><i><b>d</b></i></sup></a> <a href="#_ref-HanauerCrohns_e" title=""><sup><i><b>e</b></i></sup></a> {{cite journal}}</li><li id="_note-51"><b><a href="#_ref-51" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-52"><b><a href="#_ref-52" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-53"><b><a href="#_ref-53" title="">&uarr;</a></b> British Medical Journal <a class="externallink" href="http://gut.bmj.com/cgi/content/full/55/1/136" rel="nofollow" title="http://gut.bmj.com/cgi/content/full/55/1/136">A proof of concept study establishing Necator americanus in Crohn’s patients and reservoir donors</a></li><li id="_note-54"><b><a href="#_ref-54" title="">&uarr;</a></b> Daily Mail. <a class="externallink" href="http://www.dailymail.co.uk/pages/live/articles/technology/technology.html?in_article_id=481875&#38;in_page_id=1965" rel="nofollow" title="http://www.dailymail.co.uk/pages/live/articles/technology/technology.html?in_article_id=481875&#38;in_page_id=1965"> The bloodsucking worm that fights allergies from inside your tummy</a> 14-09-2007.</li><li id="_note-55"><b><a href="#_ref-55" title="">&uarr;</a></b> <a class="externallink" href="http://www.kuro5hin.org/story/2006/4/30/91945/8971" rel="nofollow" title="http://www.kuro5hin.org/story/2006/4/30/91945/8971">How to cure your asthma or hayfever using hookworm - a practical guide</a>. 01-05-2006.</li><li id="_note-56"><b><a href="#_ref-56" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-Hiatt">&uarr; <a href="#_ref-Hiatt_a" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Hiatt_b" title=""><sup><i><b>b</b></i></sup></a> {{cite journal}}</li><li id="_note-58"><b><a href="#_ref-58" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-59"><b><a href="#_ref-59" title="">&uarr;</a></b> {{cite journal}}</li><li id="_note-60"><b><a href="#_ref-60" title="">&uarr;</a></b> Satsangi J, Jewell DP, Bell JI.  The genetics of inflammatory bowel disease and they are sick and we too.  Gut. 1997 May;40(5):572-4.  PMID 9203931.</li><li id="_note-61"><b><a href="#_ref-61" title="">&uarr;</a></b> Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B.  Ulcerative colitis and Crohn&#39;s disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking.  <i>Gut</i> 1988 Jul;29(7):990-6.  PMID 3396969</li><li id="_note-62"><b><a href="#_ref-62" title="">&uarr;</a></b> Kirsner JB.  Historical aspects of inflammatory bowel disease.  <i>J Clin Gastroenterol.</i> 1988 Jun;10(3):286-97.  PMID 2980764</li></ol></div>

<a id="External_links" name="External_links"></a><h1>External links</h1>

<ul>
<li>{{DMOZ}}</li></ul>
<p>{{Gastroenterology}}</p>
<p>





</p>
<p><a href="http://cs.wikipedia.org/wiki/Crohnova_choroba">cs:Crohnova choroba</a>
<a href="http://de.wikipedia.org/wiki/Morbus_Crohn">de:Morbus Crohn</a>
<a href="http://es.wikipedia.org/wiki/Enfermedad_de_Crohn">es:Enfermedad de Crohn</a>
<a href="http://eo.wikipedia.org/wiki/Crohn-malsano">eo:Crohn-malsano</a>
<a href="http://eu.wikipedia.org/wiki/Crohn_gaitza">eu:Crohn gaitza</a>
<a href="http://fr.wikipedia.org/wiki/Maladie_de_Crohn">fr:Maladie de Crohn</a>
<a href="http://gl.wikipedia.org/wiki/Mal_de_Crohn">gl:Mal de Crohn</a>
<a href="http://hr.wikipedia.org/wiki/Crohnova_bolest">hr:Crohnova bolest</a>
<a href="http://it.wikipedia.org/wiki/Morbo_di_Crohn">it:Morbo di Crohn</a>
<a href="http://he.wikipedia.org/wiki/מ%D7%97%D7%9C%D7%AA_%D7%A7%D7%A8%D7%95%D7%94%D7%9F">he:מחלת קרוהן</a>
<a href="http://nl.wikipedia.org/wiki/Ziekte_van_Crohn">nl:Ziekte van Crohn</a>
<a href="http://ja.wikipedia.org/wiki/ク%E3%83%AD%E3%83%BC%E3%83%B3%E7%97%85">ja:クローン病</a>
<a href="http://no.wikipedia.org/wiki/Crohns_sykdom">no:Crohns sykdom</a>
<a href="http://pl.wikipedia.org/wiki/Choroba_Le%C5%9Bniowskiego-Crohna">pl:Choroba Leśniowskiego-Crohna</a>
<a href="http://pt.wikipedia.org/wiki/Doen%C3%A7a_de_Crohn">pt:Doença de Crohn</a>
<a href="http://ru.wikipedia.org/wiki/Б%D0%BE%D0%BB%D0%B5%D0%B7%D0%BD%D1%8C_%D0%9A%D1%80%D0%BE%D0%BD%D0%B0">ru:Болезнь Крона</a>
<a href="http://simple.wikipedia.org/wiki/Crohn%26%2339%3Bs_disease">simple:Crohn&#39;s disease</a>
<a href="http://sk.wikipedia.org/wiki/Crohnova_choroba">sk:Crohnova choroba</a>
<a href="http://sl.wikipedia.org/wiki/Crohnova_bolezen">sl:Crohnova bolezen</a>
<a href="http://fi.wikipedia.org/wiki/Crohnin_tauti">fi:Crohnin tauti</a>
<a href="http://sv.wikipedia.org/wiki/Crohns_sjukdom">sv:Crohns sjukdom</a>
<a href="http://tr.wikipedia.org/wiki/Crohn_hastal%C4%B1%C4%9F%C4%B1">tr:Crohn hastalığı</a>
<a href="http://zh.wikipedia.org/wiki/克%E9%9A%86%E6%B0%8F%E7%97%87">zh:克隆氏症</a>
</p>